Paper40790282
Advances in PET imaging of protein aggregates associated with neurodegenerative disease.
Higuchi M and 3 others. Nat Rev Neurol, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Advances in PET imaging of protein aggregates associated with neurodegenerative disease. Papers, record 40790282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40790282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neurodegenerative Diseases | Major topic |
| Positron-Emission Tomography | Major topic |
| Protein Aggregates | Major topic |
| Protein Aggregation, Pathological | Major topic |
| Humans | |
| tau Proteins | |
| Amyloid beta-Peptides | |
| alpha-Synuclein |
Source PubMed
References177
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37663501 | A Fluorescent Probe as a Lead Compound for a Selective α-Synuclein PET Tracer: Development of a Library of 2-Styrylbenzothiazoles and Biological Evaluation of [18F]PFSB and [18F]MFSB. | ACS Omega | 2023 | https://conductscience.org/library/papers/37663501 | PubMed |
| 2 | 27314820 | [F-18]AV-1451 positron emission tomography retention in choroid plexus: More than "off-target" binding. | Ann Neurol | 2016 | https://conductscience.org/library/papers/27314820 | PubMed |
| 3 | 32956648 | Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein. | Brain Res | 2020 | https://conductscience.org/library/papers/32956648 | PubMed |
| 4 | 25824567 | Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study. | Alzheimers Dement | 2015 | https://conductscience.org/library/papers/25824567 | PubMed |
| 5 | 35344984 | Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. | Nature | 2022 | https://conductscience.org/library/papers/35344984 | PubMed |
| 6 | 25534025 | Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. | Acta Neuropathol | 2015 | https://conductscience.org/library/papers/25534025 | PubMed |
| 7 | 30938796 | Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. | JAMA | 2019 | https://conductscience.org/library/papers/30938796 | PubMed |
| 8 | 27997036 | Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. | Ann Neurol | 2017 | https://conductscience.org/library/papers/27997036 | PubMed |
| 9 | 30857558 | Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. | Acta Neuropathol Commun | 2019 | https://conductscience.org/library/papers/30857558 | PubMed |
| 10 | 35513543 | Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43. | Acta Neuropathol | 2022 | https://conductscience.org/library/papers/35513543 | PubMed |
| 11 | 22749065 | Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. | Lancet Neurol | 2012 | https://conductscience.org/library/papers/22749065 | PubMed |
| 12 | 30326496 | Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2018 | https://conductscience.org/library/papers/30326496 | PubMed |
| 13 | 34089275 | Clinical Utility of 18 F-APN-1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy. | Mov Disord | 2021 | https://conductscience.org/library/papers/34089275 | PubMed |
| 14 | 37421950 | Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies. | Cell | 2023 | https://conductscience.org/library/papers/37421950 | PubMed |
| 15 | 31264169 | Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies. | Eur J Nucl Med Mol Imaging | 2019 | https://conductscience.org/library/papers/31264169 | PubMed |
| 16 | 33165511 | Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. | JAMA Neurol | 2020 | https://conductscience.org/library/papers/33165511 | PubMed |
| 17 | 32671408 | 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. | Brain | 2020 | https://conductscience.org/library/papers/32671408 | PubMed |
| 18 | 23234879 | Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. | J Alzheimers Dis | 2013 | https://conductscience.org/library/papers/23234879 | PubMed |
| 19 | 28678775 | Cryo-EM structures of tau filaments from Alzheimer's disease. | Nature | 2017 | https://conductscience.org/library/papers/28678775 | PubMed |
| 20 | 24860424 | Protein phosphorylation in neurodegeneration: friend or foe? | Front Mol Neurosci | 2014 | https://conductscience.org/library/papers/24860424 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927299 | PET-based molecular imaging in neurodegeneration and dementia: current and emerging radiotracers. | Radiol Adv | 2026 | https://conductscience.org/library/papers/42927299 | PubMed |
| 42894080 | Radiosynthesis and quality control testing of two 18F-labeled radiopharmaceuticals for α-synuclein imaging in clinical investigations. | EJNMMI Radiopharm Chem | 2026 | https://conductscience.org/library/papers/42894080 | PubMed |
| 42720909 | Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring. | Mol Diagn Ther | 2026 | https://conductscience.org/library/papers/42720909 | PubMed |
| 42547799 | High prevalence of tau pathologies in late-onset psychosis: A PET study. | Mol Psychiatry | 2026 | https://conductscience.org/library/papers/42547799 | PubMed |
| 42394416 | Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42394416 | PubMed |
| 41002384 | Imaging of Proteinopathies in the Brains of Parkinsonian Disorders. | Cells | 2025 | https://conductscience.org/library/papers/41002384 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| FUS | 2521 | PubTator's text mining | https://conductscience.org/library/genes/2521 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
| TARDBP | 23435 | PubTator's text mining | https://conductscience.org/library/genes/23435 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40790282
GET https://conductscience.org/api/papers/v1/40790282/references?page=2